Yanan Cheng

952 total citations
34 papers, 690 citations indexed

About

Yanan Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanan Cheng has authored 34 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Yanan Cheng's work include BRCA gene mutations in cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yanan Cheng is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Yanan Cheng collaborates with scholars based in China, United States and Saudi Arabia. Yanan Cheng's co-authors include Pu Xu, Hui Fan, Xiaoli Jia, Jinpu Yu, Enqi Liu, Shuangsuo Dang, Ping Song, Baofeng Wang, Lei Han and Xin Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Scientific Reports.

In The Last Decade

Yanan Cheng

30 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanan Cheng China 13 372 205 87 80 76 34 690
Jianjun Liu China 13 405 1.1× 313 1.5× 159 1.8× 106 1.3× 92 1.2× 35 956
Zijie Su China 17 411 1.1× 141 0.7× 95 1.1× 54 0.7× 36 0.5× 44 708
Xing Zhou China 16 391 1.1× 170 0.8× 146 1.7× 147 1.8× 168 2.2× 55 982
Chun‐Yi Chuang Taiwan 18 514 1.4× 221 1.1× 160 1.8× 47 0.6× 105 1.4× 56 963
Kelong Ma China 17 959 2.6× 415 2.0× 111 1.3× 67 0.8× 71 0.9× 42 1.2k
Xiaoyu Cao China 17 486 1.3× 101 0.5× 113 1.3× 104 1.3× 61 0.8× 53 897
Qiuchen Qi China 11 506 1.4× 163 0.8× 96 1.1× 59 0.7× 104 1.4× 19 746
Juanjuan Qiu China 16 389 1.0× 143 0.7× 124 1.4× 30 0.4× 50 0.7× 35 667

Countries citing papers authored by Yanan Cheng

Since Specialization
Citations

This map shows the geographic impact of Yanan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanan Cheng more than expected).

Fields of papers citing papers by Yanan Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanan Cheng. The network helps show where Yanan Cheng may publish in the future.

Co-authorship network of co-authors of Yanan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yanan Cheng. A scholar is included among the top collaborators of Yanan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanan Cheng. Yanan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Yao, Jianjun Yan, Yanan Cheng, et al.. (2025). Coal dust particles can upregulate the expression of NLRP3 inflammasome components in rat alveolar macrophages through phagocytosis. Scientific Reports. 15(1). 8989–8989.
3.
Han, Lei, James H. Liu, Yanan Cheng, et al.. (2025). Insights From Nonsense‐Mediated mRNA Decay for Prognosis in Homologous Recombination‐Deficient Ovarian Cancer. Cancer Science. 116(5). 1449–1463.
4.
Zhang, Yao, et al.. (2024). Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study. Frontiers in Cellular and Infection Microbiology. 14. 1348685–1348685. 6 indexed citations
5.
Cheng, Yanan, et al.. (2024). Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma. Cancer Imaging. 24(1). 75–75. 6 indexed citations
6.
Cheng, Yanan, Dechao Bu, Qiaoling Zhang, et al.. (2022). Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer. Journal of Advanced Research. 51. 121–134. 24 indexed citations
7.
Wang, Yan, Longyan Yang, Lin Mao, et al.. (2022). SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways. Cancer Cell International. 22(1). 74–74. 41 indexed citations
8.
Wang, Ke, et al.. (2021). A hereditary ovarian cancer family with rare pathogenic splicing mutation: Implications for variant interpretation. Cancer Genetics. 256-257. 127–130. 1 indexed citations
9.
Song, Yu, et al.. (2020). HHIP Overexpression Suppresses Human Gastric Cancer Progression and Metastasis by Reducing Its CpG Island Methylation. Frontiers in Oncology. 10. 1667–1667. 10 indexed citations
10.
Li, Xiaoni, et al.. (2020). Nano-pearl powder/chitosan-hyaluronic acid porous composite scaffold and preliminary study of its osteogenesis mechanism. Materials Science and Engineering C. 111. 110749–110749. 28 indexed citations
11.
Shi, Yehui, Wenwen Zhang, Yanan Cheng, et al.. (2018). Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway. Cancer Biology and Medicine. 15(3). 314–314. 5 indexed citations
12.
Zhang, Wenbo, et al.. (2018). IL-13 -1112 polymorphism and periodontitis susceptibility: a meta-analysis. BMC Oral Health. 18(1). 21–21. 12 indexed citations
13.
Liu, Pengpeng, Rui Zhang, Wenwen Yu, et al.. (2017). FGF1 and IGF1-conditioned 3D culture system promoted the amplification and cancer stemness of lung cancer cells. Biomaterials. 149. 63–76. 32 indexed citations
14.
Yu, Yang, Li Dong, Dapeng Li, et al.. (2015). Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer. Scientific Reports. 5(1). 16129–16129. 22 indexed citations
15.
Ye, Yingnan, Pengpeng Liu, Yue Wang, et al.. (2014). Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway. International Reviews of Immunology. 35(4). 340–350. 12 indexed citations
16.
Wang, Baofeng, Xi-Jing Wang, Huafeng Kang, et al.. (2014). Saikosaponin-D Enhances Radiosensitivity of Hepatoma Cells under Hypoxic Conditions by Inhibiting Hypoxia-Inducible Factor-1a. Cellular Physiology and Biochemistry. 33(1). 37–51. 43 indexed citations
17.
Wang, Baofeng, Zhijun Dai, Xi-Jing Wang, et al.. (2013). Saikosaponin-d increases the radiosensitivity of smmc-7721 hepatocellular carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the cell cycle. BMC Complementary and Alternative Medicine. 13(1). 263–263. 37 indexed citations
18.
Dang, Shuangsuo, Xiaoli Jia, Ping Song, et al.. (2009). Inhibitory effect of emodin and Astragalus polysaccharideon the replication of HBV. World Journal of Gastroenterology. 15(45). 5669–5669. 56 indexed citations
19.
Dang, Shuangsuo, Xiaoli Jia, Yanan Cheng, et al.. (2008). Protective effects of emodin and astragalus polysaccharides on chronic hepatic injury in rats. Chinese Medical Journal. 121(11). 1010–1014. 39 indexed citations
20.
Dang, Shuangsuo, Xiaoli Jia, Yanan Cheng, et al.. (2004). Inhibitory effect ofHuangqi Zhechongdecoction on liver fibrosis in rat. World Journal of Gastroenterology. 10(15). 2295–2295. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026